White Paper

Is it worth the risk?

April 15, 2015

The pharmaceutical supply chain is subject to many types of risk, among them the introduction of counterfeit products, poor planning of inventory levels and delays to distribution. Product quality in the cold chain is also a key consideration. There is a perception in the industry that as outsourcing becomes more prevalent these risks are becoming harder to control. Sue Lee of World Courier looks at risk-mitigation strategies that pharmaceutical companies can deploy to maintain control of increasingly complex and globalised supply chains.

Download to find out more.